Drug Trial Radar · NCT04233346
The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation
Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
93
Actual
Start
Jul 9, 2020
Primary completion
Jul 22, 2022
Study completion Sep 8, 2026
Sponsor
- Lead sponsor
- Otsuka Beijing Research InstituteOtsuka
- Sponsor type
- Industry
- First posted
- Jan 18, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This protocol will allow ponatinib with refractory Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia
Conditions
- Chronic Myeloid Leukemia
- Acute Lymphoblastic Leukemia
Interventions
Ponatinib 30mg ODDrug
Ponatinib 30mg OD
Ponatinib 45mg ODDrug
Ponatinib 45mg OD
Primary outcomes
What the sponsor says the trial is designed to measure.
- MCyR(Major Cytogenetic Response) of CP-CML patientsTime frame: 12 months
- MaHR(Major Hematologic Response) of AP-CML, BP-CML and Ph+ ALL patients by 6 monthsTime frame: 6 months
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
1st affiliated hospital, Peking University
Beijing, China
Hematology Hospital, Chinese Academy of Medical Sciences
Tianjin, China
Anhui Provincial Hospital
Hefei, Anhui, China
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, China
Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Xiangya Hospital Central South University
Changsha, Hunan, China
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
Qilu Hospital of Shandong University
Jinan, Shandong, China
Second hospital of Shanxi Medical University
Taiyuan, Shanxi, China
Shenzhen Second People's Hospital
Shenzhen, Shenzhen, China
West China Hospital, Sichuan University
Chengdu, Sichuan, China
The First Affiliated Hospital of Medical School of Zhejiang University
Hangzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.